Pelabresib

DB17129InvestigationalSmall molecule

Pelabresib: Overview.

Chemical structure of Pelabresib
Formula / weight
C20H16ClN3O2 · 365.82 g/mol (avg)
Also known as
2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-isoxazolo(5,4-d)(2)benzazepin-4-yl)acetamide · 4h-isoxazolo(5,4-d)(2)benzazepine-4-acetamide, 6-(4-chlorophenyl)-1-methyl-, (4s) · CPI-0610 anhydrous · Pelabresib anhydrous
Code names
CPI-232 · CPI-267232 · DAK539

Resolves to

Compound
UNIIU4017GUQ06CAS1380087-89-7ChEMBLCHEMBL4303404ChEBI189653
Clinical / RWD
ATCL01XX84
Structure
InChIKeyGCWIQUVXWZWCLE-INIZCTEOSA-NSMILESCC1=NOC2=C1C1=C(C=CC=C1)C(=N[C@H]2CC(N)=O)C1=CC=C(Cl)C=C1
Targets
O60885BRD4

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 3 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Pelabresib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In